Keryx Suffers Setback As Diabetic Nephropathy Candidate Fails Phase III Study

Firm falls back on mid-stage pipeline candidates in chronic kidney disease, kidney cancer.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet